Relative of low CSF Aβ42 in pathology of amyloidosis (A+) in PD group (28.16%) and HC group (30.59%) had no differences in CSF NfL baseline concentration between A + and A-groups (Figure 1C). This evidence concerns the gene NEFL and Parkinson disease.